Sarepta Therapeutics (SRPT) Appoints Edward Kaye as Permanent CEO; Updates on Exec Team
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/18/2024
- European stocks gain as dollar eases, oil prices fall
- Taiwan Semi (TSM) Q1 profit beats expectations on AI demand
- Dollar rally stalls after rare FX warning from finance chiefs
- Oil stabilises after sharp drop on demand concerns, easing of Middle East tension
- Netflix's subscribers, TSMC, Tesla upside - what's moving markets
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- Crude Inventory Rose 2.7 Million Barrels Last Week, Says EIA
- Lithium Americas Corp (LAC) Announces Proposed 55M Share Offering
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
Form 8-K Sarepta Therapeutics, For: Sep 20
September 21, 2016 8:31 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
... MoreForm 8-K Sarepta Therapeutics, For: Sep 20
September 20, 2016 5:24 PM EDTUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
... More
